Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 51

1.

Effectiveness of the 10-valent pneumococcal conjugate vaccine among girls, boys, preterm and low-birth-weight infants - Results from a randomized, double-blind vaccine trial.

Nieminen H, Rinta-Kokko H, Jokinen J, Puumalainen T, Moreira M, Borys D, Schuerman L, Palmu AA.

Vaccine. 2019 Jun 19;37(28):3715-3721. doi: 10.1016/j.vaccine.2019.05.033. Epub 2019 May 20.

2.

Effectiveness of the ten-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) against all respiratory tract infections in children under two years of age.

Karppinen S, Toivonen L, Schuez-Havupalo L, Teros-Jaakkola T, Waris M, Auranen K, Palmu AA, Peltola V.

Vaccine. 2019 May 16;37(22):2935-2941. doi: 10.1016/j.vaccine.2019.04.026. Epub 2019 Apr 23.

PMID:
31027929
3.

Impact of Childhood Pneumococcal Conjugate Vaccine on Nonnotified Clinically Suspected Invasive Pneumococcal Disease in Australia.

Gidding HF, Sheridan S, Fathima P, Moore HC, Liu B, McIntyre PB, Palmu AA; ACIR Linkage Investigator Team.

Pediatr Infect Dis J. 2019 Aug;38(8):860-865. doi: 10.1097/INF.0000000000002314.

PMID:
30985507
4.

Culture of all sputum samples irrespective of quality adds value to the diagnosis of pneumococcal community-acquired pneumonia in the elderly.

Saukkoriipi A, Palmu AA, Jokinen J.

Eur J Clin Microbiol Infect Dis. 2019 Jul;38(7):1249-1254. doi: 10.1007/s10096-019-03536-9. Epub 2019 Apr 4.

5.

Nasal swab bacteriology by PCR during the first 24-months of life: A prospective birth cohort study.

Palmu AA, Ware RS, Lambert SB, Sarna M, Bialasiewicz S, Seib KL, Atack JM, Nissen MD, Grimwood K.

Pediatr Pulmonol. 2019 Mar;54(3):289-296. doi: 10.1002/ppul.24231. Epub 2019 Jan 4.

PMID:
30609299
6.

Re: "First Otitis Media and Pneumococcal Conjugate Vaccine Serotypes in Infants".

Palmu AA, Lahdenkari M.

Pediatr Infect Dis J. 2018 Dec;37(12):e352-e353. doi: 10.1097/INF.0000000000002036. No abstract available.

PMID:
30408014
7.

The prevalence of otitis media in 2-3 year old Cameroonian children estimated by tympanometry.

Libwea JN, Kobela M, Ndombo PK, Syrjänen RK, Huhtala H, Fointama N, Koulla-Shiro S, Nohynek H, Nuorti JP, Palmu AA.

Int J Pediatr Otorhinolaryngol. 2018 Dec;115:181-187. doi: 10.1016/j.ijporl.2018.10.007. Epub 2018 Oct 6.

8.

Effectiveness and impact of the 10-valent pneumococcal conjugate vaccine, PHiD-CV: review of clinical trials and post-marketing experience.

Mrkvan T, Pelton SI, Ruiz-Guiñazú J, Palmu AA, Borys D.

Expert Rev Vaccines. 2018 Sep;17(9):797-818. doi: 10.1080/14760584.2018.1516551. Review.

PMID:
30185083
9.

Effectiveness of pneumococcal Haemophilus influenzae protein D conjugate vaccine against pneumonia in children: A cluster-randomised trial.

Kilpi TM, Jokinen J, Puumalainen T, Nieminen H, Ruokokoski E, Rinta-Kokko H, Traskine M, Lommel P, Moreira M, Ruiz-Guinazu J, Borys D, Schuerman L, Palmu AA.

Vaccine. 2018 Sep 18;36(39):5891-5901. doi: 10.1016/j.vaccine.2018.08.020. Epub 2018 Aug 23.

10.

The association of adverse events with bivalent human papilloma virus vaccination: A nationwide register-based cohort study in Finland.

Skufca J, Ollgren J, Artama M, Ruokokoski E, Nohynek H, Palmu AA.

Vaccine. 2018 Sep 18;36(39):5926-5933. doi: 10.1016/j.vaccine.2018.06.074. Epub 2018 Aug 13.

11.

Register-Based Ecologic Evaluation of Safety Signals Related to Pneumococcal Conjugate Vaccine in Children.

Artama M, Rinta-Kokko H, Nohynek H, Jokinen J, Palmu AA.

Curr Drug Saf. 2018;13(2):107-112. doi: 10.2174/1574886313666180406164151.

12.

A pneumococcal conjugate vaccination programme reduced clinically suspected invasive disease in unvaccinated children.

Palmu AA, Rinta-Kokko H, Nuorti JP, Nohynek H, Jokinen J.

Acta Paediatr. 2018 Mar 25. doi: 10.1111/apa.14335. [Epub ahead of print]

PMID:
29577411
13.

Long-term impact of 10-valent pneumococcal conjugate vaccination on invasive pneumococcal disease among children in Finland.

Rinta-Kokko H, Palmu AA, Auranen K, Nuorti JP, Toropainen M, Siira L, Virtanen MJ, Nohynek H, Jokinen J.

Vaccine. 2018 Apr 5;36(15):1934-1940. doi: 10.1016/j.vaccine.2018.03.001. Epub 2018 Mar 8.

PMID:
29526371
14.

Vaccine-preventable disease incidence of pneumococcal conjugate vaccine in the Finnish invasive pneumococcal disease vaccine trial.

Palmu AA, Jokinen J, Nieminen H, Rinta-Kokko H, Ruokokoski E, Puumalainen T, Moreira M, Schuerman L, Borys D, Kilpi TM.

Vaccine. 2018 Mar 27;36(14):1816-1822. doi: 10.1016/j.vaccine.2018.02.088.

15.

Testing Pneumonia Vaccines in the Elderly: Determining a Case Definition for Pneumococcal Pneumonia in the Absence of a Gold Standard.

Jokinen J, Snellman M, Palmu AA, Saukkoriipi A, Verlant V, Pascal T, Devaster JM, Hausdorff WP, Kilpi TM.

Am J Epidemiol. 2018 Jun 1;187(6):1295-1302. doi: 10.1093/aje/kwx373.

16.
17.

lytA Quantitative PCR on Sputum and Nasopharyngeal Swab Samples for Detection of Pneumococcal Pneumonia among the Elderly.

Saukkoriipi A, Palmu AA, Pascal T, Verlant V, Hausdorff WP, Jokinen J.

J Clin Microbiol. 2017 Dec 26;56(1). pii: e01231-17. doi: 10.1128/JCM.01231-17. Print 2018 Jan.

18.

Impact of National Ten-Valent Pneumococcal Conjugate Vaccine Program on Reducing Antimicrobial Use and Tympanostomy Tube Placements in Finland.

Palmu AA, Rinta-Kokko H, Nohynek H, Nuorti JP, Jokinen J.

Pediatr Infect Dis J. 2018 Jan;37(1):97-102. doi: 10.1097/INF.0000000000001810.

PMID:
29088026
19.

Population-level impact of infant 10-valent pneumococcal conjugate vaccination on adult pneumonia hospitalisations in Finland.

Okasha O, Rinta-Kokko H, Palmu AA, Ruokokoski E, Jokinen J, Nuorti JP.

Thorax. 2018 Mar;73(3):262-269. doi: 10.1136/thoraxjnl-2017-210440. Epub 2017 Oct 7.

PMID:
28988217
20.

Direct and Indirect Effectiveness of the 10-Valent Pneumococcal Conjugate Vaccine Against Carriage in a Cluster Randomized Trial.

Palmu AA, Toropainen M, Kaijalainen T, Siira L, Lahdenkari M, Nieminen H, Syrjänen RK, Kilpi TM, Jokinen J.

Pediatr Infect Dis J. 2017 Dec;36(12):1193-1200. doi: 10.1097/INF.0000000000001705.

PMID:
28737627
21.

Impact of ten-valent pneumococcal conjugate vaccine on pneumonia in Finnish children in a nation-wide population-based study.

Palmu AA, Rinta-Kokko H, Nohynek H, Nuorti JP, Kilpi TM, Jokinen J.

PLoS One. 2017 Mar 1;12(3):e0172690. doi: 10.1371/journal.pone.0172690. eCollection 2017.

22.

Similar Antibody Levels in 3-Year-Old Children Vaccinated Against Measles, Mumps, and Rubella at the Age of 12 Months or 18 Months.

Kontio M, Palmu AA, Syrjänen RK, Lahdenkari M, Ruokokoski E, Davidkin I, Vaarala O, Melin M.

J Infect Dis. 2016 Jun 15;213(12):2005-13. doi: 10.1093/infdis/jiw058. Epub 2016 Feb 9.

PMID:
26908733
23.

Evaluation of the BinaxNOW® Streptococcus pneumoniae antigen test on fresh, frozen and concentrated urine samples in elderly patients with and without community-acquired pneumonia.

Saukkoriipi A, Pascal T, Palmu AA.

J Microbiol Methods. 2016 Feb;121:24-6. doi: 10.1016/j.mimet.2015.12.007. Epub 2015 Dec 9.

PMID:
26684855
24.

Effectiveness of the Ten-valent Pneumococcal Conjugate Vaccine Against Tympanostomy Tube Placements in a Cluster-randomized Trial.

Palmu AA, Jokinen J, Nieminen H, Rinta-Kokko H, Ruokokoski E, Puumalainen T, Traskine M, Moreira M, Borys D, Schuerman L, Kilpi TM.

Pediatr Infect Dis J. 2015 Nov;34(11):1230-5. doi: 10.1097/INF.0000000000000857.

PMID:
26284652
25.

Pneumococcal Conjugate Vaccine and Clinically Suspected Invasive Pneumococcal Disease.

Palmu AA, Kilpi TM, Rinta-Kokko H, Nohynek H, Toropainen M, Nuorti JP, Jokinen J.

Pediatrics. 2015 Jul;136(1):e22-7. doi: 10.1542/peds.2015-0458. Epub 2015 Jun 15.

26.

Health benefit for the child and promotion of the common good were the two most important reasons for participation in the FinIP vaccine trial.

Nieminen H, Syrjänen RK, Puumalainen T, Sirén P, Palmu AA.

Vaccine. 2015 Jul 17;33(31):3695-702. doi: 10.1016/j.vaccine.2015.06.010. Epub 2015 Jun 11.

PMID:
26073011
27.

Efficacy of the 7-Valent Pneumococcal Conjugate Vaccine Against Acute Otitis Media Caused by Serotype 6C Pneumococcus.

Palmu AA, Kaijalainen T, Jokinen J, Kilpi TM.

Pediatr Infect Dis J. 2015 Jul;34(7):796-7. doi: 10.1097/INF.0000000000000728.

PMID:
25886787
28.

Impact of ten-valent pneumococcal conjugate vaccination on invasive pneumococcal disease in Finnish children--a population-based study.

Jokinen J, Rinta-Kokko H, Siira L, Palmu AA, Virtanen MJ, Nohynek H, Virolainen-Julkunen A, Toropainen M, Nuorti JP.

PLoS One. 2015 Mar 17;10(3):e0120290. doi: 10.1371/journal.pone.0120290. eCollection 2015.

29.

Applied public health research on the frontline.

Palmu AA, Käyhty H.

Lancet Infect Dis. 2015 Apr;15(4):365-6. doi: 10.1016/S1473-3099(15)70052-6. Epub 2015 Feb 18. No abstract available.

PMID:
25701562
30.

Effect of antimicrobial use on pneumococcal diagnostic tests in elderly patients with community-acquired pneumonia.

Saukkoriipi A, Palmu AA, Jokinen J, Verlant V, Hausdorff WP, Kilpi TM.

Eur J Clin Microbiol Infect Dis. 2015 Apr;34(4):697-704. doi: 10.1007/s10096-014-2278-5. Epub 2014 Nov 21.

PMID:
25413924
31.

Vaccine effectiveness of the pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) against clinically suspected invasive pneumococcal disease: a cluster-randomised trial.

Palmu AA, Jokinen J, Nieminen H, Syrjänen R, Ruokokoski E, Puumalainen T, Moreira M, Schuerman L, Borys D, Kilpi TM.

Lancet Respir Med. 2014 Sep;2(9):717-27. doi: 10.1016/S2213-2600(14)70139-0. Epub 2014 Aug 7.

PMID:
25127244
32.

Incidence and etiology of community-acquired pneumonia in the elderly in a prospective population-based study.

Palmu AA, Saukkoriipi A, Snellman M, Jokinen J, Torkko P, Ziegler T, Kaijalainen T, Hausdorff WP, Verlant V, Kilpi TM.

Scand J Infect Dis. 2014 Apr;46(4):250-9. doi: 10.3109/00365548.2013.876509. Epub 2014 Jan 29.

PMID:
24475952
33.

Effect of pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) on outpatient antimicrobial purchases: a double-blind, cluster randomised phase 3-4 trial.

Palmu AA, Jokinen J, Nieminen H, Rinta-Kokko H, Ruokokoski E, Puumalainen T, Borys D, Lommel P, Traskine M, Moreira M, Schuerman L, Kilpi TM.

Lancet Infect Dis. 2014 Mar;14(3):205-12. doi: 10.1016/S1473-3099(13)70338-4. Epub 2013 Nov 26.

PMID:
24287186
34.

Long-term effect of pneumococcal conjugate vaccines on tympanostomy tube placements.

Sarasoja I, Jokinen J, Lahdenkari M, Kilpi T, Palmu AA.

Pediatr Infect Dis J. 2013 May;32(5):517-20. doi: 10.1097/INF.0b013e31827c9bcc.

PMID:
23190780
35.

Effectiveness of the ten-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) against invasive pneumococcal disease: a cluster randomised trial.

Palmu AA, Jokinen J, Borys D, Nieminen H, Ruokokoski E, Siira L, Puumalainen T, Lommel P, Hezareh M, Moreira M, Schuerman L, Kilpi TM.

Lancet. 2013 Jan 19;381(9862):214-22. doi: 10.1016/S0140-6736(12)61854-6. Epub 2012 Nov 16. Erratum in: Lancet. 2013 May 18;381(9879):1720. Erratum in: Lancet. 2015 May 30;385(9983):2152.

PMID:
23158882
36.

Acute otitis media replacement and recurrence in the Finnish otitis media vaccine trial.

Jokinen J, Palmu AA, Kilpi T.

Clin Infect Dis. 2012 Dec;55(12):1673-6. doi: 10.1093/cid/cis799. Epub 2012 Sep 12.

PMID:
22972864
37.

Nasopharyngeal carriage of Streptococcus pneumoniae and pneumococcal urine antigen test in healthy elderly subjects.

Palmu AA, Kaijalainen T, Saukkoriipi A, Leinonen M, Kilpi TM.

Scand J Infect Dis. 2012 Jun;44(6):433-8. doi: 10.3109/00365548.2011.652162. Epub 2012 Jan 21.

PMID:
22263905
38.

Presence of capsular locus genes in immunochemically identified encapsulated and unencapsulated Streptococcus pneumoniae sputum isolates obtained from elderly patients with acute lower respiratory tract infection.

Kurola P, Erkkilä L, Kaijalainen T, Palmu AA, Hausdorff WP, Poolman J, Jokinen J, Kilpi TM, Leinonen M, Saukkoriipi A.

J Med Microbiol. 2010 Oct;59(Pt 10):1140-5. doi: 10.1099/jmm.0.016956-0. Epub 2010 Jul 8.

PMID:
20616188
39.

Otitis media and its consequences: beyond the earache.

Vergison A, Dagan R, Arguedas A, Bonhoeffer J, Cohen R, Dhooge I, Hoberman A, Liese J, Marchisio P, Palmu AA, Ray GT, Sanders EA, Simões EA, Uhari M, van Eldere J, Pelton SI.

Lancet Infect Dis. 2010 Mar;10(3):195-203. doi: 10.1016/S1473-3099(10)70012-8. Review.

PMID:
20185098
40.

Efficacy of pneumococcal conjugate vaccine against PCR-positive acute otitis media.

Palmu AA, Saukkoriipi A, Jokinen J, Leinonen M, Kilpi TM.

Vaccine. 2009 Mar 4;27(10):1490-1. doi: 10.1016/j.vaccine.2009.01.004. Epub 2009 Jan 23.

PMID:
19168111
41.

Salivary antibodies induced by the seven-valent PncOMPC conjugate vaccine in the Finnish Otitis Media Vaccine Trial.

Nurkka A, Lahdenkari M, Palmu AA, Käyhty H; FinOM Study Group.

BMC Infect Dis. 2005 May 27;5:41.

42.

Diagnostic value of tympanometry using subject-specific normative values.

Palmu AA, Syrjänen R.

Int J Pediatr Otorhinolaryngol. 2005 Jul;69(7):965-71. Epub 2005 Mar 16.

PMID:
15911016
43.

Association of clinical signs and symptoms with pneumococcal acute otitis media by serotype--implications for vaccine effect.

Palmu AA, Jokinen JT, Kaijalainen T, Leinonen M, Karma P, Kilpi TM.

Clin Infect Dis. 2005 Jan 1;40(1):52-7. Epub 2004 Dec 6.

PMID:
15614692
44.

The seven-valent pneumococcal conjugate vaccine reduces tympanostomy tube placement in children.

Palmu AA, Verho J, Jokinen J, Karma P, Kilpi TM.

Pediatr Infect Dis J. 2004 Aug;23(8):732-8.

PMID:
15295223
45.

No evidence of Mycoplasma pneumoniae in acute myringitis.

Kotikoski MJ, Kleemola M, Palmu AA.

Pediatr Infect Dis J. 2004 May;23(5):465-6.

PMID:
15131474
46.

Does the presence of pneumococcal DNA in middle-ear fluid indicate pneumococcal etiology in acute otitis media?

Palmu AA, Saukkoriipi PA, Lahdenkari MI, Kuisma LK, Makela PH, Kilpi TM, Leinonen M.

J Infect Dis. 2004 Mar 1;189(5):775-84. Epub 2004 Feb 16.

PMID:
14976593
47.

Association of clinical signs and symptoms with bacterial findings in acute otitis media.

Palmu AA, Herva E, Savolainen H, Karma P, Mäkelä PH, Kilpi TM.

Clin Infect Dis. 2004 Jan 15;38(2):234-42. Epub 2003 Dec 19.

PMID:
14699456
48.

The epidemiology of acute bullous myringitis and its relationship to recurrent acute otitis media in children less than 2 years of age.

Kotikoski MJ, Palmu AA, Huhtala H, Savolainen H, Puhakka HJ.

Int J Pediatr Otorhinolaryngol. 2003 Nov;67(11):1207-12.

PMID:
14597372
49.

The symptoms and clinical course of acute bullous myringitis in children less than two years of age.

Kotikoski MJ, Palmu AA, Puhakka HJ.

Int J Pediatr Otorhinolaryngol. 2003 Feb;67(2):165-72.

PMID:
12623153
50.

Evaluation of the role of respiratory viruses in acute myringitis in children less than two years of age.

Kotikoski MJ, Palmu AA, Nokso-Koivisto J, Kleemola M.

Pediatr Infect Dis J. 2002 Jul;21(7):636-41.

PMID:
12237595

Supplemental Content

Loading ...
Support Center